SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
urine sodium level |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine sodium amount |
male |
126 days
| 7 |
260.49 |
mmol/l |
36.69 |
97.07 |
urine sodium analysis |
0.0 |
0 |
102139 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
urine potassium level |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine potassium amount |
male |
126 days
| 7 |
80.72 |
mmol/l |
27.0 |
71.44 |
urine potassium analysis |
0.0 |
0 |
102144 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
urine creatinine level |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine creatinine amount |
male |
126 days
| 7 |
12.38 |
mg/dl |
3.61 |
9.54 |
urine creatinine analysis |
0.0 |
0 |
102154 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
heart left ventricle weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart left ventricle mass |
male |
126 days
| 0 |
3.12 |
mg/g |
0.24 |
|
post excision weight measurement |
0.0 |
0 |
102115 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
urine urea level to urine creatinine level ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine urea amount |
male |
126 days
| 7 |
101.15 |
null |
8.47 |
22.41 |
urine urea analysis |
0.0 |
0 |
103794 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
both kidneys wet weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
kidney mass |
male |
126 days
| 0 |
4.16 |
g/kg |
0.4 |
|
post excision weight measurement |
0.0 |
0 |
102123 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
urine urea level |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine urea amount |
male |
126 days
| 7 |
316.61 |
mmol/l |
113.57 |
300.48 |
urine urea analysis |
0.0 |
0 |
102149 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
heart weight to body weight ratio |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
heart mass |
male |
126 days
| 0 |
4.26 |
g/kg |
0.3 |
|
post excision weight measurement |
0.0 |
0 |
102106 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
water drink intake rate |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
drinking behavior trait |
male |
126 days
| 7 |
57.55 |
ml/d |
15.23 |
40.29 |
metabolic cage water drinking measurement method |
0.0 |
0 |
102129 |
2646 |
SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc |
timed urine volume |
vehicle control condition (for 126 days) then sodium chloride solution (1 %) (for 21 days) |
Koh-Tan HH, et al., J Hypertens. 2017 Feb;35(2):319-329. doi: 10.1097/HJH.0000000000001155. |
urine output |
male |
126 days
| 7 |
30.68 |
ml/d |
11.32 |
29.95 |
metabolic cage urine volume measurement method |
0.0 |
0 |
102134 |
2646 |